Inventor · disambiguated record
Philip A. Goliber
Also filed as: GOLIBER PHILIP · GOLIBER PHILIP A
7 granted patents·5 pending applications·15 citations·filing 2003–2018
81Inventor score
Files withENDO PHARMACEUTICALS INC5BAICHWAL ANAND R2GOLIBER PHILIP A1PENWEST PHARMACEUTICALS CO1PURDUE PHARMA LP1
Top patents by PatentIndex Score
12 records- 0187US8394812B2Sustained release formulations of nalbuphineBAICHWAL ANAND R·Filed 2008·Granted Mar 12, 2013·9 cites·57 claims
- 0278US8771732B2Sustained release formulations of nalbuphineBAICHWAL ANAND R·Filed 2006·Granted Jul 8, 2014·3 cites·24 claims
- 0373US9351938B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·1 cites·24 claims
- 0472US8765175B2Sustained release formulation of nalbuphinePENWEST PHARMACEUTICALS CO·Filed 2013·Granted Jul 1, 2014·1 cites·37 claims
- 0570US9186330B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·1 cites·37 claims
- 0667US10406106B2Sustained release formulations of nalbuphineENDO PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·0 cites·21 claims
- 0763US10172798B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·0 cites·24 claims
- 0857US2016263035A1Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0954US2017100337A1Naltrexone hydrochloride compositionsPURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 1051US2007104778A1Controlled-release emulsion compositionsZENG HONGXIA·Filed 2006·Application pending·0 cites
- 1148US2003229111A1Naltrexone hydrochloride compositionsFiled 2003·Application pending·0 cites
- 1247US2006074059A1Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-oneGOLIBER PHILIP A·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →